|
Geoff Frampton: Evidence-based health technology and environmental research Welcome!
Within SHTAC I have contributed to or managed systematic reviews on a wide range of topics, including the clinical effectiveness of health technologies for managing asthma, weight, type 2 diabetes, various cancers, cardiovascular conditions, eye conditions, dermatological conditions, infectious diseases and healthcare-acquired infections. I have also managed reviews of diagnostic test assessments. I routinely contribute to or lead an "Evidence Review Group" team within SHTAC that critically appraises company evidence submissions to the UK National Institute for Health and Care Excellence (NICE) as part of the NICE Technology Appraisal Process. My current activities include (among others): investigating how to improve scientific rigour of evidence synthesis without making the process onerous and impractical; applying lessons learnt in health technology assessments to environmental research (and vice versa); optimising evidence synthesis approaches to support risk assessments; optimising the use of patient-reported outcome instruments; integrating systematic mapping and systematic review approaches to address the needs of policymakers and other stakeholders; and (time permitting...) debunking misleading scientific and media reports (e.g. that drinking alcohol reduces the risk and severity of rheumatoid arthritis - debunked here). I am a member of the editorial board of
Environmental Evidence,
which is the journal of the
Collaboration for Environmental Evidence, and I have contributed to the
development of guidance and training for the
European Food Safety Authority for the
application of systematic reviews in risk assessments of food and feed safety.
For further information on my work please follow the links -
and I welcome your comments or enquiries!
|